31133799|t|Decreased Glycogenolysis by miR-338-3p Promotes Regional Glycogen Accumulation Within the Spinal Cord of Amyotrophic Lateral Sclerosis Mice.
31133799|a|Metabolic dysfunction is a hallmark of age-related neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS). But the crosstalk between metabolic alteration and disease progression in ALS is still largely unknown. Glycogen, a branched polymer of glucose residues, is universally recognized as the energy reserve of the central nervous system (CNS), where its aberrant accumulation instigates neurodegeneration. Glycogen was reported to be accumulated in both CNS and visceral organs of SOD1G93A mice, a well-known ALS model, and contributes to the pathological process of ALS. However, the accumulative patterns and mechanisms are not well elucidated. Here, we provide extensive evidence to demonstrate that glycogen accumulated in the lumbar spinal cord of ALS mice along with the disease progression, but not in the motor cortex. This regional accumulation of glycogen was caused by deteriorated glycogenolysis, which was triggered by decreased glycogen phosphorylase, brain form (PYGB). Moreover, miR-338-3p, an elevated miRNA in the spinal cord of SOD1G93A mice, directly targeted PYGB and was responsible for the decreased glycogenolysis and subsequent glycogen accumulation. Our work is helpful for better understanding of of of metabolic dysfunctions in ALS and provides novel targets for the therapeutic intervention in the future.
31133799	57	65	Glycogen	Chemical	MESH:D006003
31133799	105	134	Amyotrophic Lateral Sclerosis	Disease	MESH:D000690
31133799	135	139	Mice	Species	10090
31133799	141	162	Metabolic dysfunction	Disease	MESH:D008659
31133799	180	218	age-related neurodegenerative diseases	Disease	MESH:D019636
31133799	230	259	amyotrophic lateral sclerosis	Disease	MESH:D000690
31133799	261	264	ALS	Disease	MESH:D000690
31133799	341	344	ALS	Disease	MESH:D000690
31133799	371	379	Glycogen	Chemical	MESH:D006003
31133799	403	410	glucose	Chemical	MESH:D005947
31133799	549	566	neurodegeneration	Disease	MESH:D019636
31133799	568	576	Glycogen	Chemical	MESH:D006003
31133799	643	651	SOD1G93A	CellLine	CVCL:C0CZ
31133799	652	656	mice	Species	10090
31133799	671	674	ALS	Disease	MESH:D000690
31133799	729	732	ALS	Disease	MESH:D000690
31133799	865	873	glycogen	Chemical	MESH:D006003
31133799	915	918	ALS	Disease	MESH:D000690
31133799	919	923	mice	Species	10090
31133799	1019	1027	glycogen	Chemical	MESH:D006003
31133799	1140	1144	PYGB	Gene	110078
31133799	1218	1222	mice	Species	10090
31133799	1242	1246	PYGB	Gene	110078
31133799	1315	1323	glycogen	Chemical	MESH:D006003
31133799	1392	1414	metabolic dysfunctions	Disease	MESH:D008659
31133799	1418	1421	ALS	Disease	MESH:D000690
31133799	Association	MESH:D006003	110078
31133799	Association	MESH:D006003	MESH:D019636
31133799	Positive_Correlation	MESH:D006003	MESH:D000690

